NATIONAL COMPETITIVE BIDDING (NCB) Legislation Status and Comparison ITEM H. R. 4954S. 3018S. 3098 # Pages255 pages296 pages28 SponsorRep. Nancy Johnson.

Slides:



Advertisements
Similar presentations
By: Kevin Tang.  -Senator Robert Wagner tries to pass National Health Act of Fails.  -On November 19, 1945,President Truman outlined a comprehensive,
Advertisements

Leading through change S T A T E O F T H E D I S T R I C T
Medicaid Opportunities & Challenges Task Force June 26, 2013 Jeff Bechtel, Senior Consultant Summary of Congressional Budget Office Reports and Analysis.
 Medicare Drug Rebates  Medicare patients who face a gap in prescription drug coverage would received a one-year, $250 rebate to help pay for medication.
Beneficiary Taking it to the. National Competitive Bidding vs. Patient Choice.
MedPAC Hospice Payment Adequacy Meeting Summary at a Glance: The Medicare Payment Advisory Commission (MedPAC) met 12/11/09 and commissioners heard a staff.
May 20, Budget Shortfall Projected in January Budget $(19.9) Special Session Solutions 1.4 Achieved Federal Funding 0.7 Revenue Decline (0.6) Cost.
CAH OIG Report and Recommendations Friday, September 27, 2013 Elizabeth G. Cobb MPH Kentucky Hospital Association.
1 Medical Assistance Program (report 11-15) Legislative Audit Bureau February 2012.
MEDICARE: PAST, PRESENT AND F UTURE James G. Anderson, Ph.D. Department of Sociology & Anthropology.
High-Income Medicare Recipients to Pay Surcharge By ROBERT PEAR Published: September 12, 2006
Chapter 4 Lecture 1 Tax Planning and Strategies. Why Understand Taxes? Knowledge of the tax laws can help you: Knowledge of the tax laws can help you:
Congressional Budget Office Presentation to The Tax Policy Center and the American Tax Policy Institute Taxes and Health Insurance February 29, 2008.
Medicare and the New Prescription Drug Benefit Presented by Tricia Neuman, Sc.D. Vice President and Director, Medicare Policy Project The Henry J. Kaiser.
Medicare Improvement for Patients and Providers Act of 2008 Preliminary Summary of Beneficiary and Plan Provisions July 14 th,
A Few Facts 1.Federal spending in FY 2000 and 2001 as a percent of GDP is the lowest since Federal government spending (not including social security,
Obama Administration Outline/Proposal Broad Outline Only Would retain employer based health insurance system Includes a “play or pay” model Creates a.
Reforming the American Health Care System. Basic Facts 83% of people are satisfied with their own health care (CNN/Opinion Research July 31–August 3)
What Wonders Have They Wrought? The Patient Protection and Affordable Care Act.
Medicare Reforms LECTURE 15. Overview of 2003 Changes “The Medicare Prescription Drug, Improvement and Modernization Act of 2003” More commonly called.
The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 Presented by Tricia Neuman, Sc.D. Vice President and Director, Medicare Policy.
Issues and Challenges Facing Medicare Mark L. Hayes.
National Health Care Reform: Issues and Outlook James C. Capretta Fellow, Ethics and Public Policy Center Worldwide Employee.
Policy Changes for Older Persons. Elderly Status in 1960 Little interest in expansion of programs for aged after initial passage of SS Act in 1935 First.
Michigan Medicaid Pharmacy Cost Containment Paul Reinhart, Director Medical Services Administration Michigan Department of Community Health October 8,
FIVE YEAR FINANCIAL FORECAST OCTOBER 2011 Cleveland Municipal School District The primary goal of the Cleveland Municipal School District is to become.
A non-profit corporation and independent licensee of the Blue Cross Blue Shield Association 1 Health Reform: The Impact on Michigan Michigan Purchasers.
Florida’s Medicaid Reform Joan Alker and Jack Hoadley Georgetown Health Policy Institute, Duval County Medical Society Forum 2/23/07.
Health Care Reform Lexicon John Dante, FSA, MAAA, FCA President and CEO Dante Actuarial Consulting, LLC Actuaries Club of Philadelphia Meeting November.
The Medicare Modernization Act: Impact in 2005 Greg Spratt BS, RRT, CPFT Chief Clinical Officer Rotech Healthcare Inc.
Federal-State Policies: Implications for State Health Care Reform National Health Policy Conference February 4, 2008.
The New Medicare Prescription Drug Benefit: An Overview Prepared by: Michelle Kitchman, M.H.S. Kaiser Family Foundation For the: California Senate Health.
Medicaid “Reform” and Mental Health Leighton Ku Senior Fellow Presentation at NAMI Conference, June 2005
Slide 1 Drug Pricing Considerations Medicare Prescription Drug, Improvement, and Modernization Act of 2003 ___________ Copyright 2005 Arnold & Porter July.
CENTERS for MEDICARE & MEDICAID SERVICES Tom Scully CMS Administrator.
Impact of Restrictive State Policies on Utilization and Expenditures in the Medicaid Program Roberto Vargas, MD, MPH 1,2 Carole Gresenz, PhD 2 Jessie Riposo,
Medicare Coordinated Care Demonstration May 13, 2003.
National Academy of Social Insurance 17 th Annual Conference Washington, D.C. January 28, 2005 Is There a Better Way to Reduce Growth in Medicare Spending?
Chapter 14 Financing. Copyright © 2005 by Thomson Delmar Learning. ALL RIGHTS RESERVED.2 Personal Health Care Expenditures, 1965 Physicians 20% Nursing.
A Forecast for the Changing Environment for Medicaid and Managed Care Michigan Association Health Plans Summer Conference July 18, 2015 © 2015
6.05 New Opportunities for Drugs under Old Medicare: Changes to Inpatient New Technology Pass-Throughs and ‘Incident to’ Coverage February 27, 2004 Christopher.
Why reform? Actual Projection 2.5 Percentage Points 1 Percentage Point Zero.
February 11, 2009 Health Reform Issues and Overview Webinar One Hosted By Jud Sommer Senior Vice President, Government Affairs June 24, 2009.
Objective The aim was to assess purchasing pharmaceuticals in the public health sector in Jordan through the joint procurement for participating parties.
Avalere Health LLC | The intersection of business strategy and public policy The Medicare Modernization Act: The Impact on States and Low-Income Beneficiaries.
The following slides were part of the presentation at the 25 th annual Southwest Regional NP Symposium Angela Golden AANP Co-President American Association.
Figure 1 K A I S E R C O M M I S S I O N O N Medicaid and the Uninsured Dual Eligibles: The Basics Barbara Lyons, Ph.D. Director, Kaiser Commission on.
1 Medicare Reform: Implications for Pharmaceutical Manufacturers G. Lawrence Atkins, PhD Schering-Plough Corporation January 14, 2004.
Federal Affairs Update Molina Policy & Government Advocacy Summit Ken Preede Director, Federal Affairs.
THE AFFORDABLE HEALTH CARE ACT CRYSTAL DAVIS FRANK GRAESER NABIL HAMAM MARY ANN JORDAN THOMAS KEITH THERESA STARUCH.
Patient Centered Health Care – At a Crossroads Alliance for Health Reform Congressman Tom Price, M.D. June 6, 2008.
Estimating the Cost of the Medicare Drug Benefit Philip Ellis Steve Lieberman Medicare Prescription Drug Congress February 27, 2004.
Justine Strand de Oliveira, DrPH, PA-C. Objective: Describe the major features of the Patient Protection and Affordable Care Act (PPACA) that will impact.
Home and Community Based Services Policy Forum March 15, 2016 Peter Notarstefano, Director of Home and Community Based Services.
340B PROGRAM AND BEST PRICE LAW HIGPA 2003 National Pharmacy Forum February 4, 2003 Presentation By Ted Slafsky Director Public Hospital Pharmacy Coalition.
Health Reform’s Cost Impact Can More be Done to Bend the Cost Curve?
Health Reform Update: Work in Congress and by the Administration
Median Age by County 2010.
Issues and Challenges Facing Medicare
Total U.S. prescription drug spending, in $ billions:
How the budget and Budget Repair Bill Supports for People w/ Disabilities SC Date.
Medicare, Medicaid, and CHIP
Straight Talk for Seniors: How Will Health Care Reform Change Your Health Care? June 2013.
MMA Implementation: Issues Facing States
Projected Savings and Effectiveness of System Reform Provisions in House and Senate Reform Bills 2010–2019 (in billions) CBO Estimate of Budget Savings,
Payment and System Reform Savings from ACA Provisions, 2010–19
Medicare Rx Drug Benefit
Projected Savings and Effectiveness of System Reform Provisions in Comprehensive Reform Law 2010–19 (in billions) CBO Estimate of Budget Savings, Affordable.
Medicare Reform: Implications for Pharmaceutical Manufacturers
Major Sources of Savings and Revenues Compared with Projected Spending, Net Cumulative Effect on Federal Deficit, 2010–2019 Dollars in billions CBO estimate.
Presentation transcript:

NATIONAL COMPETITIVE BIDDING (NCB) Legislation Status and Comparison ITEM H. R. 4954S. 3018S # Pages255 pages296 pages28 SponsorRep. Nancy Johnson (R-CT)Senator Max Baucus (D-MT) Senator Charles Grassley (R-IA) Senator Bob Graham (D-FL) Senator Phil Gramm (R-TX) TitleMedicare Modernization and Prescription Drug Act of 2002 Beneficiary Access to Care and Medicare Equity Act of 2002 Medicare Competitive Acquisition Act of 2002 Current Status June 28, 02 (Passed) 221 – 208 July 15, 02 placed on Senate Legislative Calendar Oct 3, 02 Introduced to Senate by use of Rule XIV (failed – Sen. Don Nickles (R-OK) in opposition Oct 10, 02 Read twice and referred to the Committee on Finance Summary$350 Billion Bill - 10 year package. Provides Rx Drug coverage & $30 Billion > for Hospitals / Doc / Nursing Fac. $43 Billion Bill – 10 year package. Provides $30 Billion “give back” to Hospitals / Doc / Nursing Fac. $12.8 Billion Rural Health “Stand alone” Bill to impose Competitive Bidding. Does not include MSA’s of 500k “Carve – out” found in S Sec # for NCB Section 511 – Titled “V: Provisions relating to Part B” Section 311 – Titled “Competitive Acquisition of Certain Items & Serv.” Section 2 – Titled “Competitive Acquisition of Items and Services” Phase –In time frame Not longer than 3 years, 1/3 areas in 04 & 2/3 areas in 05 Not longer than 4 years, ¼ area 03 2/4 area in 04 w/ no less ¾ by 05 Not longer than 4 years, ¼ in 03 at least 2/4 in 04 w/ ¾ by 05 Impact loss to HME CBO projected $7.7 Bil savings 6,000 Small Business Close 60,000 employees laid off CBO projection $5.8 Bil Savings 4,500 Small Business Close 45,000 employees laid off CBO projected $7.7 Bil savings 6,000 Small Business Close 60,000 employees laid off

Aftermath of CMS takeover In the demonstration sites, fewer than 25% of providers won Medicare contracts Of non-participants, only 20% can survive long- term without Medicare patients National chains will dominate Negative impact on beneficiaries, including rural areas Industry – post NCB

Aftermath of CMS Takeover 60% of the nation’s independent dealers out of business Severe change in seniors’ access to their preferred provider Providers forced to reduce the quality of product service to become lower cost providers Halting of innovation in home care products

CBO Estimates for NCB CBO estimated gross 10 year savings of competitive bidding at $7.7 billion $5.8 million of this “savings” reverts to the US Treasury

Cost of Bureaucracy? CMS administrative costs for the demonstration were 56% of the gross savings Demonstration sites

Questions on the rate of growth The future growth rate of homecare spending is subject to estimates. CBO’s growth estimate results in 33% greater homecare expenditures as compared to CMS’s estimated growth rate Growth in Homecare ($B)

Behind the numbers Administrative costs at demonstration sites were 56% of gross savings CBO analysis assumed higher growth rate than CMS. Splitting the difference reduces gross savings by $1 billion This does not even include the reduction in income tax collections Little “savings” left for federal government

Conclusions 1.The costs and likely “savings” from competitive bidding are still unknown –No objective analysis performed to date –Significant uncertainties in the assumptions –Huge negative impact on access, service, quality and innovation –Canada tried it and it failed –Fails the smell test – eliminates many businesses, increases the size and control of federal government